Min Huang

2.5k total citations
94 papers, 1.8k citations indexed

About

Min Huang is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Min Huang has authored 94 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 32 papers in Cancer Research and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Min Huang's work include Cancer Immunotherapy and Biomarkers (23 papers), Breast Cancer Treatment Studies (21 papers) and Economic and Financial Impacts of Cancer (20 papers). Min Huang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (23 papers), Breast Cancer Treatment Studies (21 papers) and Economic and Financial Impacts of Cancer (20 papers). Min Huang collaborates with scholars based in United States, China and United Kingdom. Min Huang's co-authors include Hao Wu, Yongqian Shu, Amin Haiderali, Thomas Burke, Naomi Rosenberg, James M. Pellissier, Peng Cao, Ping Liu, Ruifeng Xu and Yanyan Lou and has published in prestigious journals such as Journal of Clinical Oncology, Genes & Development and Cancer Research.

In The Last Decade

Min Huang

85 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min Huang United States 22 735 598 507 422 198 94 1.8k
Benjamin Levy United States 23 966 1.3× 526 0.9× 503 1.0× 1.1k 2.7× 136 0.7× 97 1.9k
Joseph A. Pinto Peru 18 703 1.0× 622 1.0× 505 1.0× 405 1.0× 184 0.9× 90 1.6k
Stephen Welch Canada 24 1.0k 1.4× 626 1.0× 279 0.6× 388 0.9× 96 0.5× 124 1.9k
Jonathan Krell United Kingdom 29 814 1.1× 1.4k 2.4× 1.3k 2.6× 278 0.7× 195 1.0× 126 2.6k
Umang Swami United States 21 727 1.0× 468 0.8× 282 0.6× 634 1.5× 176 0.9× 173 1.6k
David J. Bentrem United States 26 819 1.1× 767 1.3× 582 1.1× 194 0.5× 227 1.1× 51 2.0k
Michael Schrauder Germany 24 745 1.0× 846 1.4× 982 1.9× 254 0.6× 56 0.3× 62 2.1k
Erika Cecchin Italy 27 1.5k 2.0× 1.2k 2.0× 363 0.7× 406 1.0× 204 1.0× 125 2.6k
Richard Turkington United Kingdom 16 1.2k 1.6× 689 1.2× 499 1.0× 379 0.9× 155 0.8× 59 2.0k
Fortunato Ciardiello Italy 23 1.7k 2.3× 435 0.7× 456 0.9× 697 1.7× 222 1.1× 79 2.3k

Countries citing papers authored by Min Huang

Since Specialization
Citations

This map shows the geographic impact of Min Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Huang more than expected).

Fields of papers citing papers by Min Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Huang. The network helps show where Min Huang may publish in the future.

Co-authorship network of co-authors of Min Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Min Huang. A scholar is included among the top collaborators of Min Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Huang. Min Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Mengyuan, et al.. (2025). The Prognostic Value of Tumor‐Associated Neutrophils in Colorectal Cancer: A Systematic Review and Meta‐Analysis. Cancer Medicine. 14(5). e70614–e70614. 2 indexed citations
2.
3.
Chen, Yen‐Hsu, Zone‐Ching Lin, Mi Zhou, et al.. (2024). P1.08C.03 Updated Event-Free Survival of Tislelizumab Plus Chemotherapy Asneoadjuvant/adjuvant Therapy for Stage IIB-IIIC NSCLC (lungmark Study). Journal of Thoracic Oncology. 19(10). S181–S181. 1 indexed citations
4.
Huang, Min, Ou Xu, Shuo Sun, et al.. (2024). Diagnostic and prognostic values of HCG15 and morrbid in acute myocardial infarction. Frontiers in Pharmacology. 15. 1492746–1492746. 3 indexed citations
5.
Huang, Min, Jessica Weaver, Elamin H. Elbasha, et al.. (2024). Cost-Effectiveness Analysis of Routine Childhood Immunization with 20-Valent versus 15-Valent Pneumococcal Conjugate Vaccines in Germany. Vaccines. 12(9). 1045–1045. 2 indexed citations
6.
Zhang, Rui, Qianqian Liu, Liyan Zhang, et al.. (2024). Comparison of clopidogrel and ticagrelor in treating acute coronary syndrome undergoing PCI: A systematic review and meta-analysis. Heliyon. 10(5). e26553–e26553.
7.
Huang, Min, Peter A. Fasching, Amin Haiderali, et al.. (2023). Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in the United States. Advances in Therapy. 40(3). 1153–1170. 14 indexed citations
8.
9.
10.
Huang, Min, Peter A. Fasching, Amin Haiderali, et al.. (2023). Association Between Event-Free Survival and Overall Survival in Early-Stage Triple-Negative Breast Cancer. Future Oncology. 20(6). 335–348. 1 indexed citations
11.
Liu, Qianqian, Haitong Zhao, Tingting He, et al.. (2023). Prognostic value of lymph node micrometastasis in esophageal cancer: A systematic review and meta-analysis. Frontiers in Oncology. 12. 1025855–1025855. 3 indexed citations
12.
Huang, Yuyan, Bo Peng, Min Huang, et al.. (2022). The top 100 most cited articles on triple-negative breast cancer: a bibliometric analysis. Clinical and Experimental Medicine. 23(2). 175–201. 8 indexed citations
13.
Huang, Min, et al.. (2021). Conceptual Framework and Methodological Challenges for Modeling Effectiveness in Oncology Treatment Sequence Models. PharmacoEconomics. 40(3). 257–268. 6 indexed citations
14.
Huang, Min, Joyce O’Shaughnessy, Jing Zhao, et al.. (2020). Association of Pathologic Complete Response with Long-Term Survival Outcomes in Triple-Negative Breast Cancer: A Meta-Analysis. Cancer Research. 80(24). 5427–5434. 89 indexed citations
15.
Frederickson, Andrew M., et al.. (2019). PCN468 SYSTEMATIC REVIEW OF UTILITY ESTIMATES IN TRIPLE-NEGATIVE BREAST CANCER PATIENTS. Value in Health. 22. S527–S528. 1 indexed citations
16.
Frederickson, Andrew M., et al.. (2019). PCN132 SYSTEMATIC REVIEW OF ECONOMIC BURDEN IN TRIPLE-NEGATIVE BREAST CANCER PATIENTS. Value in Health. 22. S461–S461. 1 indexed citations
17.
Ye, Qin, Shauna N. Vasilatos, Lin Chen, et al.. (2018). Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade. Oncogene. 38(3). 390–405. 166 indexed citations
18.
Huang, Min, Hao Wu, Jing Zhou, Min Xu, & Suming Zhou. (2018). Efficacy of Vancomycin on Gram-Positive Bacterial Infection in Elderly Critical Patients and Risk Factors Associated With Nephrotoxicity.. PubMed. 21(8). 349–355. 19 indexed citations
19.
Huang, Min, James M. Pellissier, & Jason J. Z. Liao. (2016). Healthcare Resource Utilization in Patients Receiving Pembrolizumab or Docetaxel with Previously Treated Advanced NSCLC. Value in Health. 19(7). A755–A755. 2 indexed citations
20.
Bai, Hui, Nan Li, Chenchen Wang, et al.. (2014). GRP78 inhibits macrophage adhesion via SR-A. Journal of Biomedical Research. 28(4). 269–269. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin Levy Breakdown of academic impact, for papers by Joseph A. Pinto Breakdown of academic impact, for papers by Stephen Welch Breakdown of academic impact, for papers by Jonathan Krell Breakdown of academic impact, for papers by Umang Swami Breakdown of academic impact, for papers by David J. Bentrem Breakdown of academic impact, for papers by Michael Schrauder Breakdown of academic impact, for papers by Erika Cecchin Breakdown of academic impact, for papers by Richard Turkington Breakdown of academic impact, for papers by Fortunato Ciardiello
Rankless by CCL
2026